InvestSMART

Company announcements

leave blank for all companies
leave blank for all announcements
announcements

~ We have limited the announcement data displayed on our website to the past 12 months to ensure its accuracy and usefulness.
Search Results
Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 One-month administrative delay to FDA meeting for HIE 9 Dec 2025 10:38AM $19.940 $16.340 fallen by 18.05%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Application for quotation of securities - NEU 24 Nov 2025 5:43PM $18.380 $16.340 fallen by 11.10%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Investor Presentation, 10 November 2025 10 Nov 2025 8:46AM $18.580 $16.340 fallen by 12.06%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Record DAYBUE net sales of US$101.1 million in Q3 2025 6 Nov 2025 9:59AM $20.230 $16.340 fallen by 19.23%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Fast Track granted by FDA for NNZ-2591 in Phelan-McDermid 20 Oct 2025 9:28AM $20.650 $16.340 fallen by 20.87%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Change of registered office in Australia 17 Oct 2025 4:44PM $20.650 $16.340 fallen by 20.87%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Application for quotation of securities - NEU 3 Oct 2025 4:58PM $21.500 $16.340 fallen by 24%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Notification regarding unquoted securities - NEU 22 Sep 2025 7:30AM $19.820 $16.340 fallen by 17.56%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Neuren partners with Hope for HIE to support NNZ-2591 9 Sep 2025 7:30AM $20.800 $16.340 fallen by 21.44%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Change of Director's Interest Notice 8 Sep 2025 7:08PM $20.800 $16.340 fallen by 21.44%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Application for quotation of securities - NEU 28 Aug 2025 4:43PM $19.510 $16.340 fallen by 16.25%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Investor Presentation, 27 August 2025 27 Aug 2025 11:21AM $17.930 $16.340 fallen by 8.87%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 H1 2025 profit after tax A$15m, up from A$8m in H1 2024 27 Aug 2025 9:24AM $17.800 $16.340 fallen by 8.20%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Half Yearly Report and Accounts 27 Aug 2025 9:21AM $17.800 $16.340 fallen by 8.20%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 First site initiated for Neuren's PMS Phase 3 trial 25 Aug 2025 9:27AM $17.170 $16.340 fallen by 4.83%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 First site initiated for Neuren's PMS Phase 3 trial 25 Aug 2025 9:27AM $17.170 $16.340 fallen by 4.83%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Application for quotation of securities - NEU 12 Aug 2025 4:12PM $17.880 $16.340 fallen by 8.61%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Neuren adds SYNGAP1-related disorder to NNZ-2591 pipeline 8 Aug 2025 9:16AM $17.550 $16.340 fallen by 6.89%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 DAYBUE Q2 2025 net sales US$96.1 million up 14% from Q2 2024 7 Aug 2025 9:51AM $17.010 $16.340 fallen by 3.94%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 DAYBUE Q2 2025 net sales US$96.1 million up 14% from Q2 2024 7 Aug 2025 9:51AM $17.010 $16.340 fallen by 3.94%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Change of Director's Interest Notice - J Pilcher 22 Jul 2025 9:30AM $15.170 $16.340 risen by 7.71%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Application for quotation of securities - NEU 22 Jul 2025 9:21AM $15.170 $16.340 risen by 7.71%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Notification regarding unquoted securities - NEU 9 Jul 2025 5:03PM $14.180 $16.340 risen by 15.23%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Application for quotation of securities - NEU 30 Jun 2025 5:49PM $14.110 $16.340 risen by 15.80%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 US patent allowed for NNZ-2591 to treat Pitt Hopkins 26 Jun 2025 9:25AM $12.540 $16.340 risen by 30.30%

51 - 75 of 821 results

Page 3 of 33

  • + Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.